MAXHEALTH - Swing Trade Analysis with AI Signals
Back to ListSwing Trade Rating: 3.4
| Stock Code | MAXHEALTH | Market Cap | 97,634 Cr. | Current Price | 1,004 ₹ | High / Low | 1,314 ₹ |
| Stock P/E | 141 | Book Value | 87.4 ₹ | Dividend Yield | 0.15 % | ROCE | 12.5 % |
| ROE | 9.45 % | Face Value | 10.0 ₹ | DMA 50 | 1,043 ₹ | DMA 200 | 1,102 ₹ |
| Chg in FII Hold | -1.25 % | Chg in DII Hold | 1.17 % | PAT Qtr | 160 Cr. | PAT Prev Qtr | 166 Cr. |
| RSI | 47.9 | MACD | -24.2 | Volume | 46,92,119 | Avg Vol 1Wk | 42,89,714 |
| Low price | 934 ₹ | High price | 1,314 ₹ | PEG Ratio | 4.46 | Debt to equity | 0.08 |
| 52w Index | 18.4 % | Qtr Profit Var | -30.6 % | EPS | 6.60 ₹ | Industry PE | 44.0 |
📊 Max Healthcare (MAXHEALTH) shows a cautious outlook for swing trading. The stock trades at ₹1,004, below both its 50 DMA (₹1,043) and 200 DMA (₹1,102), reflecting short-term weakness. RSI at 47.9 indicates neutral momentum, while MACD at -24.2 signals bearish pressure. Valuation is stretched with a P/E of 141 compared to industry average of 44.0, and PEG ratio of 4.46 suggests expensive growth. Fundamentals remain moderate with ROE at 9.45% and ROCE at 12.5%. EPS of ₹6.60 and low debt-to-equity (0.08) provide some support, while DII buying (+1.17%) offsets FII selling (-1.25%).
✅ Optimal Entry Price: Around ₹980–1,000 (near support zone, slightly below current price).
🚪 Exit Strategy (if already holding): Consider exit near ₹1,080–1,100 (resistance zone close to 200 DMA). If price falls below ₹970, apply stop-loss to protect capital.
Positive
- 📈 EPS of ₹6.60 supports valuation stability.
- 💹 ROCE (12.5%) and ROE (9.45%) show moderate efficiency.
- ⚡ Low debt-to-equity ratio (0.08).
- 🏦 DII holdings increased (+1.17%).
- 📊 Strong trading volume above weekly average.
Limitation
- ⚠️ Very high P/E (141 vs industry 44.0).
- 📉 PEG ratio (4.46) indicates expensive growth.
- 📉 Trading below both 50 DMA and 200 DMA.
- 📉 Dividend yield is very low (0.15%).
Company Negative News
- 📉 FII holdings decreased (-1.25%).
- ⚠️ Quarterly PAT declined (₹160 Cr. vs ₹166 Cr.).
- 📉 Profit variation worsened (-30.6%).
Company Positive News
- 📈 DII accumulation signals domestic investor confidence.
- ⚡ Debt-free structure provides financial stability.
Industry
- 🏥 Healthcare sector average PE is 44.0, MAXHEALTH trades at a steep premium (141).
- 📊 Sector demand remains resilient, supported by rising healthcare needs.
Conclusion
⚖️ MAXHEALTH is a moderately weak candidate for swing trading due to stretched valuation, declining profits, and bearish technicals. Entry near ₹980–1,000 offers limited risk-reward, while exits should be targeted near ₹1,080–1,100. Strong DII support and low debt provide positives, but traders should remain cautious and apply strict stop-loss discipline below ₹970.